BlackRock Advisors’s Evolent Health EVH Stock Holding History

BlackRock Advisors’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$123K	Sell	8,295 -245	-3%	-$4.83K	﹤0.01%	2945
2016 Q3	$210K	Buy	8,540 +3,811	+81%	+$89.1K	﹤0.01%	2662
2016 Q2	$91K	Buy	4,729 +952	+25%	+$13.1K	﹤0.01%	3013
2016 Q1	$40K	Hold	3,777	–	–	﹤0.01%	3226
2015 Q4	$46K	Sell	3,777 -1,990	-35%	-$29.3K	﹤0.01%	3227
2015 Q3	$92K	Sell	5,767 -421,133	-99%	-$8.22M	﹤0.01%	3133
2015 Q2	$8.32M	Buy	+426,900	New	+$7.96M	0.01%	817

Other funds holding EVH

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

BlackRock Advisors's EVH Position: Q4 2016 in Review

BlackRock Advisors reduced its Evolent Health (EVH) stake by 2.9% in Q4 2016, selling an estimated $4.83K and leaving 8,295 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #2945.

BlackRock Advisors first reported a position in EVH in Q2 2015 and has held it in 7 quarters since. The position peaked at $8.32M in Q2 2015. 118 funds tracked by Wall St. Rank hold EVH as of Q4 2016.

BlackRock Advisors held 8,295 shares of Evolent Health worth $123K as of Q4 2016.
BlackRock Advisors sold 245 Evolent Health shares in Q4 2016, an estimated $4.83K.
Evolent Health made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2945 holding.
BlackRock Advisors first reported a position in Evolent Health in Q2 2015 and has held it in 7 quarters since.
BlackRock Advisors's Evolent Health position peaked at $8.32M in Q2 2015.
118 funds tracked by Wall St. Rank held Evolent Health as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.